PLK1 antibodies detect the human PLK1 protein (UniProt ID: P53350), which regulates centrosome maturation, spindle assembly, and cytokinesis . These antibodies are widely used in techniques such as Western blot (WB), immunofluorescence (IF), immunoprecipitation (IP), and flow cytometry (FC) .
Mechanistic Insights: PLK1 is overexpressed in cancers (e.g., lung adenocarcinoma, breast cancer) and promotes tumor growth by activating biosynthesis pathways like the pentose phosphate pathway via G6PD phosphorylation .
Therapeutic Targeting:
PLK1 stabilizes HIV-1-infected CD4+ T cells by enhancing SUMOylation, enabling viral reservoir persistence. Dual PLK1-BET inhibitors (e.g., UMB-151) reduce latent HIV reservoirs while reactivating virus .
PLK1 inhibition reduces global DNA methylation by destabilizing UHRF1, a key epigenetic regulator, leading to tumor suppressor gene re-expression .
High PLK1/p-PLK1 expression correlates with poor survival in NK/T cell lymphoma (5-year OS: 71.1% vs. 29.6% in low vs. high PLK1 groups) .
PLK1 overexpression in breast cancer associates with TP53 mutations and triple-negative subtypes .
Validation: Antibodies like 10305-1-AP and 3F8 show specificity via single-band WB at ~68 kDa .
Storage: Most antibodies require storage at -20°C in PBS with sodium azide and glycerol .
PLK-1, a serine/threonine kinase, plays a critical role in regulating various aspects of cell division in the nematode *Caenorhabditis elegans*. It is essential for the proper execution of key events, including:
Further research highlights the crucial and conserved role of PLK-1 in various cellular processes:
Applications : Western blot
Sample type: Human Cells
Review: Western blot assays showed that the tBHP and SAHA-induced suppression of phospho-FOXM1, AURKA and PLK1, as well as phospho-CCNB1.